Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells

Area of Science:

• Biotechnology
• Nanomedicine
• Cancer Therapy

Background:

• Ribosome-inactivating proteins (RIPs) like Saporin toxin are explored for novel cancer treatments.
• Saporin inhibits protein synthesis but suffers from poor cellular uptake.
• Conventional cancer therapies (chemo- and radiotherapy) have limitations.

Purpose of the Study:

• To enhance Saporin toxin's efficacy as a cancer therapeutic.
• To overcome the challenge of poor cellular uptake and cytosolic diffusion of Saporin.
• To investigate the potential of nanoparticle-drug conjugates for targeted cancer cell death.

Main Methods:

• Immobilizing Saporin toxin onto iron oxide nanoparticles.
• Coating nanoparticles with an amphiphilic polymer to promote endosomal escape.
• Evaluating the cytotoxic effect of Saporin-conjugated nanoparticles on cancer cell lines and fibroblasts.
• Assessing apoptosis induction and its dependence on nanoparticle concentration and surface ligand density.

Main Results:

• Saporin-conjugated nanoparticles demonstrated significant cytotoxic effects.
• Nanoconjugates effectively mediated cancer cell death through ribosomal inactivation.
• Apoptosis was induced in a nanoparticle concentration-dependent manner.
• The Saporin-nanoparticle conjugate showed selectivity, sparing healthy fibroblasts while targeting cancer cells.

Conclusions:

• Immobilizing Saporin on functionalized nanoparticles enhances its cytotoxic potential.
• Amphiphilic polymer coating facilitates endosomal escape, enabling Saporin's action.
• Saporin-conjugated nanoparticles represent a promising targeted cancer therapy with selective toxicity.